发明名称 PHARMACEUTICAL COMPOSITIONS FOR SIGNALING THE LIMPHOTOXINE-BETA RECEIVER
摘要 The invention relates to compositions for activating the limphotoxin-beta receiver signalization which, in exchange, produce potential antiproliferative effects on the tumoral cells. This invention also relates to limphotoxin heteromeric complexes formed between limphotoxin-alpha and multiple subunits of limphotoxin-beta, said complexes inducing cytotoxic effects on the tumoral cells, in the presence of the agents which activate the limphotoxin-beta receiver. The invention presents antibodies targeting against the limphotoxin-beta receiver, said antibodies acting as agents activating limphotoxin-beta receivers, said agents being alone or in combination with other agents activating the limphotoxin-beta receiver, in the presence or the absence of limphotoxin-alpha/beta complexes.
申请公布号 RO118634(B1) 申请公布日期 2003.08.29
申请号 RO19970001398 申请日期 1996.01.26
申请人 BIOGEN INC, CAMBRIDGE 发明人 BROWNING JEFFREY L;MEIER WERNER;BENJAMIN CHRISTOPHER D
分类号 G01N33/566;A61K38/00;A61K38/19;A61K38/21;A61K39/395;A61P35/00;C07K14/525;C07K14/715;C07K16/28;C12N5/20;C12P21/08;(IPC1-7):A61K38/19 主分类号 G01N33/566
代理机构 代理人
主权项
地址